title: [Postoperative radiotherapy in non-small cell lung cancer].
abstract: Postoperative radiotherapy remains controversial in non-small cell lung cancer. The conclusions of several meta-analysis are still questioned, partly because of flaws in the randomized trials taken into account. The technological improvements of modern radiotherapy and several clinical observations have led to the launch of a new phase III trial.
authors.affiliation: Département de radiothérapie-oncologie, institut Jules-Bordet, rue Heger-Bordet, 1, Bruxelles 1000, Belgique.
authors.forename: M
authors.initials: M
authors.lastname: Roelandts
authors.forename: L
authors.initials: L
authors.lastname: Moretti
authors.forename: P
authors.initials: P
authors.lastname: Van Houtte
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy* / Q000601:surgery; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D015201:Meta-Analysis as Topic; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D016896:Treatment Outcome